Your browser doesn't support javascript.
loading
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.
Bramante, Simona; Kaufmann, Johanna K; Veckman, Ville; Liikanen, Ilkka; Nettelbeck, Dirk M; Hemminki, Otto; Vassilev, Lotta; Cerullo, Vincenzo; Oksanen, Minna; Heiskanen, Raita; Joensuu, Timo; Kanerva, Anna; Pesonen, Sari; Matikainen, Sampsa; Vähä-Koskela, Markus; Koski, Anniina; Hemminki, Akseli.
Affiliation
  • Bramante S; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
  • Kaufmann JK; Oncolytic Adenovirus Group, German Cancer Research Center (Deutsches Krebsforschungszentrum [DKFZ]), Heidelberg, Germany.
  • Veckman V; Unit of Systems Toxicology, Finnish Institute of Occupational Health, Topeliuksenkatu 41 a, Helsinki, Finland.
  • Liikanen I; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
  • Nettelbeck DM; Oncolytic Adenovirus Group, German Cancer Research Center (Deutsches Krebsforschungszentrum [DKFZ]), Heidelberg, Germany.
  • Hemminki O; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
  • Vassilev L; Oncos Therapeutics Ltd., Helsinki, Finland.
  • Cerullo V; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
  • Oksanen M; Laboratory of Immunovirotherapy, Division of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Helsinki, Finland.
  • Heiskanen R; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
  • Joensuu T; Oncos Therapeutics Ltd., Helsinki, Finland.
  • Kanerva A; Docrates Cancer Center, Helsinki, Finland.
  • Pesonen S; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
  • Matikainen S; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland.
  • Vähä-Koskela M; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
  • Koski A; Unit of Systems Toxicology, Finnish Institute of Occupational Health, Topeliuksenkatu 41 a, Helsinki, Finland.
  • Hemminki A; Cancer Gene Therapy Group, Department of Pathology and Transplantation Laboratory and Haartman Institute, University of Helsinki, Finland.
Int J Cancer ; 137(7): 1775-83, 2015 Oct 01.
Article in En | MEDLINE | ID: mdl-25821063
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / Oncolytic Virotherapy / Melanoma Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Int J Cancer Year: 2015 Type: Article Affiliation country: Finland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / Oncolytic Virotherapy / Melanoma Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Int J Cancer Year: 2015 Type: Article Affiliation country: Finland